From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA issues draft guidance on biosimilars interchange

from Pharmacy Practice News

Nearly two years after approving the nation’s first biosimilar, the FDA released its draft guidance recommending how sponsors of proposed therapeutic proteins can demonstrate interchangeability with reference products when applying for marketing approval. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063